28 November 2017: The Federal Ministers give a final decision (positive) for this trial
Trial reference:
A phase II study evaluating the efficacy and the safety of first-line chemotherapy combined with TG4010 and nivolumab in patients with advanced non-squamous Non-Small-Cell Lung Cancer (NSCLC)